Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD)
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
controls derived from the current literature. We strongly suggest that while we may take argument concerning many of these so-called controls (e.g. blood donors) it is quite remarkable that there are a plethora of case -control studies indicating selective association of these risk alleles ( measured in GARS) for the most part indicating a hypodopaminergia. The paper presents the detailed methodology of the GARS. Data collection procedures, instrumentation, and the analytical approach used to obtain GARS and subsequent research objectives are described. Can we combat SUD through early genetic risk screening in the addiction field enabling early intervention by the induction of dopamine homeostasis? It is envisaged that GARS type of screening will provide a novel opportunity to help identify causal pathways and associated mechanisms of genetic factors, psychological characteristics, and addictions awaiting additional scientific evidence including a future meta- analysis of all available data -a work in progress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allelic Association of Human Dopamine D2 Receptor Gene in Alcoholism
Blum, K. (1990) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1990.03440150063027 · Cited by 1,055
Self-citationReward deficiency syndrome: genetic aspects of behavioral disorders
Comings, D. E., & Blum, K. (2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26022-6 · Cited by 621
Self-citationThe D 2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome
Blum, K., Sheridan, P. J., Wood, R. C., Braverman, E. R., Chen, T. J. H., phd, J. G. C., & Comings, D. E. (1996) · Journal of the Royal Society of Medicine · doi:10.1177/014107689608900711 · Cited by 443 · cited 31×
“Author manuscript; available in PMC 2021 February 18. anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Introduction History of Reward Deficiency Syndrome (RDS) development Research into the neurogenetic basis of addiction identified and characterized by Reward Deficiency Syndrome (RDS) [1] include…”
BackgroundInfluentialSelf-citationEditor's Note: The Process Addictions and the New ASAM Definition of Addiction
Smith, D. E. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662105 · Cited by 147
Blum, K. (2018) · Frontiers in Bioscience · doi:10.2741/s518 · Cited by 143
Self-citationGenetic addiction risk score GARS trade a predictor of vulnerability to opioid dependence
Blum, K. (2018) · Frontiers in Bioscience · doi:10.2741/e816 · Cited by 104 · cited 1×
“Summary It is the goal through this novel model that by using PBM the addiction field will have a synergistic tool along with MAT or even alone, to overcome dopamine dysregulation either surfeit (adolescents) or deficit (adults) by the induction of “ dopamine homeostasis” to help attenuate SUD by enabling early interv…”
MethodSelf-citation
Cited by
Blum, K., Steinberg, B., Gondré-Lewis, M. C., Baron, D., Modestino, E. J., Badgaiyan, R. D., Downs, B. W., Bagchi, D., Brewer, R., McLaughlin, T., et al. (2021) · Psychology Research and Behavior Management · doi:10.2147/prbm.s292958 · Cited by 20
Self-citationLewandrowski, K.-U., Sharafshah, A., Elfar, J., Schmidt, S. L., Blum, K., & Wetzel, F. T. (2024) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01466-5 · Cited by 16
“The OR results indicated significance for COMT, OPRM1, DRD2, DRD3, DRD4, DAT1, and 5HTT at 5% (Blum et al. 2018, 2020, 2021; Blum et al. 2022a, b; Blum et al. 2022a, b; Fried et al. 2020; Moran et al. 2021; Bajaj et al. 2022; Dennen et al. 2022; Gondré-Lewis et al. 2022; Gupta et al. 2022;…”
BackgroundSelf-citationSummary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography
(2024) · Journal of Addiction Psychiatry · doi:10.17756/jap.2024-043 · Cited by 11
Self-citationGold, M. S., Blum, K., Bowirrat, A., Pinhasov, A., Bagchi, D., A. Dennen, C., K. Thanos, P., Hanna, C., Lewandrowski, K.-U., Sharafshah, A., et al. (2024) · INNOSC Theranostics and Pharmacological Sciences · doi:10.36922/itps.1918 · Cited by 9
Self-citation
Metadata
- Authors
- K, B., A, B., D, B., L, L., JV, P., R, B., D, S., B, B., MC, G.-L., DE, S., K Thanos, P., S, B., M, H., L, F., A, R., BW, D., & RD, B.
- Venue
- Journal of Systems and Integrative Neuroscience
- Publisher
- Open Access Text Pvt, Ltd.
- Published
- 2020
- Volume
- 6
- Issue
- 2
- ISSN
- 2059-9781 (ISSN-L)
- OpenAlex
- W3128288653
- Cited by
- 40
- References
- 6
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.